Onyx时代颅底脑膜瘤的术前栓塞:结局分析
该回顾性队列研究纳入2007—2017年在本机构接受术前栓塞的28例颅底脑膜瘤患者(28个脑膜瘤),以Onyx为主要栓塞剂,评估其安全性和有效性。结果显示中位肿瘤血运减少程度为60%,1例(4%)患者出现症状性瘤周水肿的显著神经并发症。作者认为,对于经适当选择、由硬脑膜动脉供血且远端无颅神经供血的颅底脑膜瘤,术前栓塞可获得大量肿瘤血运减少且并发症率低。
要点
- 28例颅底脑膜瘤患者行术前栓塞,中位肿瘤血运减少程度为60%。
- 1例(4%)患者Onyx栓塞后出现症状性瘤周水肿的显著神经并发症。
- 栓塞动脉蒂包括脑膜中动脉分支19例(68%)、上颌内动脉8例(29%)。
核心结论
- 对于经适当选择、由硬脑膜动脉供血且远端无颅神经供血的颅底脑膜瘤,使用当前栓塞剂技术行术前栓塞可获得大量肿瘤血运减少且并发症率低。
研究设计与样本
- 回顾性队列研究,查询本机构2007—2017年内血管数据库,纳入接受术前栓塞的颅底脑膜瘤患者28例(28个脑膜瘤)。
主要发现
- 患者平均年龄±标准差为56±13岁,女性18例(64%)。
- 平均肿瘤大小为49 cm3。
- 栓塞1、2或3支动脉蒂者分别为21例(75%)、6例(21%)和1例(4%)。
- 栓塞动脉蒂包括脑膜中动脉分支19例(68%)、上颌内动脉8例(29%)、咽升动脉2例(7%),以及耳后动脉、眼动脉、枕动脉和大脑前动脉各1例(4%)。
- 栓塞剂使用Onyx单用20例(71%)、n-butyl cyanoacrylate单用3例(11%)、弹簧圈/颗粒与Onyx/n-butyl cyanoacrylate各2例(7%)、Onyx与弹簧圈联用1例(4%)。
临床怎么用
- 作者认为,对于经适当选择、由硬脑膜动脉供血且远端无颅神经供血的颅底脑膜瘤,术前栓塞可获得大量肿瘤血运减少且并发症率低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Preoperative embolization may facilitate skull base meningioma resection, but its safety and efficacy in the Onyx era have not been investigated. In this retrospective cohort study, we evaluated the outcomes of preoperative embolization of skull base meningiomas using Onyx as the primary embolysate. METHODS: We queried an endovascular database for patients with skull base meningiomas who underwent preoperative embolization at our institution in 2007-2017. Patient, tumor, procedure, and outcome data were analyzed. RESULTS: Twenty-eight patients (28 meningiomas) underwent successful preoperative meningioma embolization. The mean patient age ± SD was 56 ± 13 years, and 18 patients (64%) were women. The mean tumor size was 49 cm3. There were 1, 2, or 3 arterial pedicles embolized in 21 cases (75%), 6 cases (21%), and 1 case (4%), respectively. The embolized pedicles included branches of the middle meningeal artery in 19 cases (68%), the internal maxillary artery in 8 cases (29%), the ascending pharyngeal artery in 2 cases (7%), and the posterior auricular, ophthalmic, occipital, and anterior cerebral arteries in 1 case each (4%). The embolysates used were Onyx alone in 20 cases (71%), n-butyl cyanoacrylate alone in 3 cases (11%), coils/particles and Onyx/n-butyl cyanoacrylate in 2 cases each (7%), and Onyx and coils in 1 case (4%). The median degree of tumor devascularization was 60%. Significant neurologic morbidity occurred in 1 patient (4%) who developed symptomatic peritumoral edema after Onyx embolization. CONCLUSIONS: For appropriately selected skull base meningiomas supplied by dura mater-based arterial pedicles without distal cranial nerve supply, preoperative embolization with current embolysate technology affords substantial tumor devascularization with a low complication rate.
引用
- Przybylowski CJ, Baranoski JF, See AP, et al. Preoperative Embolization of Skull Base Meningiomas: Outcomes in the Onyx Era. World Neurosurg. 2018. PMID: 29751190. doi:10.1016/j.wneu.2018.04.208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。